Trending at Lumira Ventures

Archemix Signs Aptamer Therapeutics Agreement with Lilly

admin Portfolio News

Archemix also strengthens IP portfolio through patent license October 20, 2008 08:30 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Archemix Corp., a biotechnology company focused on discovering, developing and commercializing aptamer therapeutics, announced today that it has signed an agreement with …